COMMUNIQUÉS West-GlobeNewswire

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

25/04/2025 - 13:59

TEL AVIV, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat [...]

Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025

25/04/2025 - 14:00

TARPON SPRINGS, Fla., April 25, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual [...]

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

25/04/2025 - 14:00

SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today [...]

VYNE Therapeutics Provides Update on VYN202 Program

25/04/2025 - 14:00

BRIDGEWATER, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) verbally informed the Company that [...]

Codetta Bio Launches Concerto™ System at AACR 2025 and Invites Attendees to Be a Part of “The Opening Concerto”

25/04/2025 - 14:00

Experience the harmony of multi-omics with Codetta Bio’s groundbreaking Concerto™ System—and be among the first to play a leading role in its debut DURHAM, N.C., April 25, 2025 (GLOBE NEWSWIRE) -- Codetta Bio is proud [...]

BioPorto announces completion of an oversubscribed directed offering of 25 million new shares raising DKK 33.5 million

25/04/2025 - 14:07

News Release April 25, 2025 BioPorto announces completion of an oversubscribed directed offering of 25 million new shares raising DKK 33.5 million COPENHAGEN, DENMARK, April 25, 2025 (GLOBE NEWSWIRE) – BioPorto, an in [...]

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

25/04/2025 - 14:08

WALTHAM, Mass. and BOULDER, Colo., April 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today [...]

Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025

25/04/2025 - 14:30

Presentation will take place during the “Developmental Therapeutics - Immunotherapy” session on May 31, 2025, from 3:00 – 6:00pm CT at McCormick Place, Chicago FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, April 25, [...]

Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement

25/04/2025 - 14:33

Aim to create the largest publicly-traded, Dogecoin-focused mining company in the world Coeptis to spin out biopharmaceutical operations WEXFORD, Pa., April 25, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, [...]

Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price

25/04/2025 - 14:45

TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced the closing of its business [...]

Better Choice Company Cancels Previously Announced Stock Dividend

25/04/2025 - 14:45

TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it is canceling the [...]

Best Testosterone Booster For Erectile Dysfunction (ED) And Muscle Building 2025: Top T Booster Supplement For Men Over 40 And 50 – By Testo Prime

25/04/2025 - 14:52

Clinically Tested Best Testosterone Booster Supplement for Men Over 40 and 50 Combines Evidence-Based Natural Ingredients Like FENUGREEK, KSM-66 Ashwagandha, VITAMIN D, D-Aspartic Acid, and Panax Ginseng to Support [...]

Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)

25/04/2025 - 15:00

Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following presentations by the Company or its collaborators at the 2025 [...]

ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints

25/04/2025 - 15:00

In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA ® (pembrolizumab), into a registrational study Company remains confident in [...]

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

25/04/2025 - 15:00

DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) (“ Mangoceuticals ” or “ MGRX ”), a company focused on developing, marketing, and selling a variety of health and wellness products via a [...]

Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025

25/04/2025 - 15:00

Hamilton, Bermuda, April 25, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB: CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets [...]

InspireMD to Announce First Quarter 2025 Financial Results

25/04/2025 - 15:00

MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced [...]

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

25/04/2025 - 15:00

BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter [...]

A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States

25/04/2025 - 12:00

LAS VEGAS, April 25, 2025 (GLOBE NEWSWIRE) -- When military service ends, many Veterans find themselves facing a new kind of battle — one marked by PTSD, addiction, and the struggle to reconnect with daily life. With an [...]